mRNA Vaccines Beyond COVID
The mRNA platform that powered COVID vaccines is being adapted for cancer treatment. Personalized cancer vaccines analyze a patient's tumor mutations and create custom mRNA sequences that teach the immune system to target those specific cells. Phase 3 trials for melanoma show a 44% reduction in recurrence when combined with immunotherapy. Clinical trials for pancreatic, lung, and colorectal cancers are underway.
